Health Care Diagnostics & Therapeutics

While drug development and therapeutics is not a specific area of investment focus (given the time and capital math), we do think there are a number of ancillary tools that can be developed to accelerate discoveries and jump start clinical trials. Fast declining sequencing costs, coupled with similar drops in DNA synthesis promise the ability to more rapidly screen pharmaceutical candidates. The keys to success are the right software design tools.